1. Home
  2. DCBO vs IVA Comparison

DCBO vs IVA Comparison

Compare DCBO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCBO
  • IVA
  • Stock Information
  • Founded
  • DCBO 2016
  • IVA 2011
  • Country
  • DCBO Canada
  • IVA France
  • Employees
  • DCBO N/A
  • IVA N/A
  • Industry
  • DCBO
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCBO
  • IVA Health Care
  • Exchange
  • DCBO Nasdaq
  • IVA Nasdaq
  • Market Cap
  • DCBO 893.7M
  • IVA 769.0M
  • IPO Year
  • DCBO 2020
  • IVA 2020
  • Fundamental
  • Price
  • DCBO $30.62
  • IVA $5.31
  • Analyst Decision
  • DCBO Strong Buy
  • IVA Strong Buy
  • Analyst Count
  • DCBO 5
  • IVA 6
  • Target Price
  • DCBO $42.20
  • IVA $15.33
  • AVG Volume (30 Days)
  • DCBO 87.6K
  • IVA 75.4K
  • Earning Date
  • DCBO 11-07-2025
  • IVA 09-26-2025
  • Dividend Yield
  • DCBO N/A
  • IVA N/A
  • EPS Growth
  • DCBO 33.51
  • IVA N/A
  • EPS
  • DCBO 0.69
  • IVA N/A
  • Revenue
  • DCBO $230,502,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • DCBO $13.02
  • IVA $80.35
  • Revenue Next Year
  • DCBO $8.37
  • IVA N/A
  • P/E Ratio
  • DCBO $44.10
  • IVA N/A
  • Revenue Growth
  • DCBO 15.11
  • IVA N/A
  • 52 Week Low
  • DCBO $25.50
  • IVA $1.53
  • 52 Week High
  • DCBO $53.86
  • IVA $6.50
  • Technical
  • Relative Strength Index (RSI)
  • DCBO 49.44
  • IVA 55.57
  • Support Level
  • DCBO $29.91
  • IVA $5.21
  • Resistance Level
  • DCBO $30.68
  • IVA $5.78
  • Average True Range (ATR)
  • DCBO 0.80
  • IVA 0.38
  • MACD
  • DCBO -0.12
  • IVA -0.06
  • Stochastic Oscillator
  • DCBO 34.63
  • IVA 39.59

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: